Brighton Jones LLC Dexcom Inc Transaction History

Brighton Jones LLC

$2.55 Billion
Q3 2024

A detailed history of Brighton Jones LLC transactions in Dexcom Inc stock. As of the latest transaction made, Brighton Jones LLC holds 4,636 shares of DXCM stock, worth $371,992. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,636

Previous 4,883 5.06%

Holding current value

$371,992

Previous $553,000 43.94%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$64.0 - $116.06 $15,808 - $28,666	-247 Reduced 5.06%	4,636 $310,000
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $441 - $561	-4 Reduced 0.08%	4,883 $553,000
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $571 - $700	-5 Reduced 0.1%	4,887 $677,000
Q4 2023 Feb 05, 2024	BUY	$75.49 - $124.16 $2,113 - $3,476	28 Added 0.58%	4,892 $607,000
Q3 2023 Oct 25, 2023	BUY	$86.06 - $137.93 $14,113 - $22,620	164 Added 3.49%	4,864 $453,000
Q2 2023 Jul 31, 2023	BUY	$112.47 - $130.98 $13,046 - $15,193	116 Added 2.53%	4,700 $603,000
Q1 2023 May 08, 2023	BUY	$104.0 - $122.92 $2,392 - $2,827	23 Added 0.5%	4,584 $532,000
Q4 2022 Feb 02, 2023	BUY	$84.98 - $122.67 $4,673 - $6,746	55 Added 1.22%	4,561 $516,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $3,893 - $4,803	51 Added 1.14%	4,506 $363,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $224,366 - $438,536	3,300 Added 285.71%	4,455 $332,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $188 - $260	-2 Reduced 0.17%	1,155 $591,000
Q4 2021 Feb 03, 2022	SELL	$129.87 - $162.82 $11,168 - $14,002	-86 Reduced 6.92%	1,157 $621,000
Q3 2021 Nov 04, 2021	SELL	$106.71 - $143.18 $14,832 - $19,902	-139 Reduced 10.06%	1,243 $680,000
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $13,282 - $17,700	164 Added 13.46%	1,382 $590,000
Q1 2021 May 07, 2021	SELL	$84.79 - $104.74 $1,017 - $1,256	-12 Reduced 0.98%	1,218 $438,000
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $9,828 - $13,167	-126 Reduced 9.29%	1,230 $455,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $5,062 - $5,986	-53 Reduced 3.76%	1,356 $559,000
Q2 2020 Aug 11, 2020	SELL	$62.68 - $105.34 $13,476 - $22,648	-215 Reduced 13.24%	1,409 $571,000
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $11,804 - $18,680	247 Added 17.94%	1,624 $437,000
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $292 - $458	-8 Reduced 0.58%	1,377 $301,000
Q3 2019 Oct 28, 2019	SELL	$35.53 - $43.8 $355 - $438	-10 Reduced 0.72%	1,385 $207,000
Q2 2019 Aug 05, 2019	BUY	$27.84 - $38.92 $38,836 - $54,293	1,395 New	1,395 $209,000
Q4 2018 Feb 08, 2019	SELL	$26.99 - $37.37 $38,568 - $53,401	-1,429 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$23.35 - $36.72 $33,367 - $52,472	1,429 New	1,429 $204,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Account

Brighton Jones LLC Dexcom Inc Transaction History